Methylphenidate HCl 10Mg SR for Breast Cancer (CogMet Trial)

"Clinicaltrials.gov affirms that this medical trial is actively searching for volunteers, having been first posted on October 9th 2017 and edited as recently as December 10th 2021."

"The inclusive age range for this medical trial is 18-75, in accordance with the predefined criteria."

"At present, 28 clinical trials for Methylphenidate HCl 10Mg SR are running. Of those active trials, 2 have advanced to Phase 3 of testing. Lexington, Kentucky is the primary site for these studies; however, 41 other medical centres across the country are also conducting research on this medication."

"Our team at Power assigned Methylphenidate HCl 10Mg SR a rating of 2 on the safety scale because it is currently undergoing Phase 2 trials and there have been some studies that attest to its security, however no evidence has emerged as yet with regard to efficacy."

"Affirmative. The clinicaltrials.gov portal shows that this medical investigation, which was first published on October 9th 2017 is currently recruiting participants. Forty individuals are needed across three different sites for this trial to be successful."

"This research requires 40 volunteers with tumors between 18 and 75 years of age. Furthermore, the following criteria must be met: Breast malignancy stage I, II or III; concluded chemotherapy/radiotherapy at least half a year prior to joining trial; remission of breast cancer; noting mental inadequacy."